About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Philadelphia | 184 Studies

Clinical Trials COPDPhiladelphia

COPD Clinical Trials in Philadelphia

Find 184 clinical trials for copd near Philadelphia, Pennsylvania. Connect with research centers in your area.

All COPD trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 184 trials

UnknownGala Early Feasibility Study of RheOxAn early feasibility study (EFS) to assess the safety and clinical utility of RheOx on patients with chronic bronchitis in the United States.NCT03631472·Birmingham, Alabama and 7 others CompletedLongitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)The study will include 60 healthy subjects (ex-smoker without any airflow limitation), 125 COPD GOLD (global initiative for chronic obstructive lung disease) I , 125 COPD GOLD II…NCT02719184·Birmingham, Alabama and 50 others

COPD Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

UnknownVibration Response Imaging (VRI) in Dyspnea Patients Presenting to the EDFor the patient with acute dyspnea in the ED, early differentiation between CHF and non-CHF causes is essential for proper management.NCT01206621·Newark, Delaware and 7 others

TerminatedA Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) SubjectsThis is a randomized, open-label, parallel group, multicenter, outpatient study in COPD subjects who are discharged from the hospital due to a COPD exacerbation.NCT02275481·Birmingham, Alabama and 27 others

CompletedInvestigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for ExacerbationsThe aim of this First Time in Patient study is to obtain initial information on the safety, tolerability, pharmacokinetics, pharmacodynamics and clinical efficacy of repeat daily…NCT02130193·Birmingham, Alabama and 15 others

RecruitingStudy of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/TrixeoChronic Obstructive Pulmonary Disease is a leading cause of global morbidity and mortality, especially in low- and middle-income countries.NCT07069829·Buenos Aires and 35 others

CompletedThe ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the DiskusThe primary objective of the trial is to show superiority in lung function of once daily (2 inhalations) treatment with orally inhaled tiotropium+olodaterol fixed dose combination…NCT03240575·Jasper, Alabama and 44 others

CompletedA Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to characterize the clinical, physiologic, and molecular profiles of healthy participants, participants with mild, moderate, and severe asthma; and…NCT01274507·Birmingham, Alabama and 20 others

CompletedInvestigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2A randomized, placebo-controlled, double-blind, parallel group, multi-center study to assess the safety and efficacy of tiotropium bromide (18 µg) delivered via the HandiHaler® in…NCT01662986·Montgomery, Alabama and 49 others

CompletedLung Tissue Research ConsortiumThe LTRC will facilitate histopathological research of pulmonary diseases by collecting lung tissues from donors and preparing and distributing collections of tissue specimens to…NCT02988388·Ann Arbor, Michigan and 3 others

UnknownStudy of Ambulatory Respiratory Assist Device in Chronic Obstructive Pulmonary Disease PatientsThe study is a two-part small scale, open-label, pilot study to evaluate feasibility and proof-of-concept for a respiratory assist medical device.NCT03531489·Philadelphia, Pennsylvania

CompletedEffect of BIBW 2948 BS in COPDStudy of BIBW 2948 BS in Patients with COPD and Chronic BronchitisNCT00423137·Birmingham, Alabama and 5 others

CompletedComparison of Time to Extubation Using Sugammadex or NeostigmineA prospective blinded randomized clinical trial to compare time to extubation using Sugammadex versus Neostigmine/glycopyrrolate as reversal agents after use of neuromuscular…NCT04606901·Philadelphia, Pennsylvania

CompletedMepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil LevelThis is a multi-center, randomized, placebo-controlled, double-blind, parallel group study designed to confirm the benefits of mepolizumab treatment on moderate or severe…NCT04133909·Birmingham, Alabama and 338 others

Active not recruitingExamining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is often caused by cigarette smoking.NCT00608764·Birmingham, Alabama and 19 others

TerminatedStudy of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)The purpose of this study is to demonstrate the safety and efficacy of AeriSeal System treatment plus optimal medical therapy compared in patients with advanced upper lobe…NCT01449292·Birmingham, Alabama and 39 others

TerminatedADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.This study evaluates the effect of two medicines on COPD (Chronic Obstructive Pulmonary Disease). The study will last 12 weeks.NCT00346749·Birmingham, Alabama and 10 others

TerminatedFunctional and Structural Assessment of Endobronchial Valve Recipients Using Dynamic Hyperpolarized Xenon-129 MRIThis study proposes to use hyperpolarized xenon-129 Magnetic Resonance Imaging (MRI) to study lung function of COPD patients who will receive endobronchial valve (EBV) therapy as…NCT05433961·Philadelphia, Pennsylvania

CompletedDetermine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPDThe purpose of this study is to assess the bronchodilator effect and safety of multiple daily doses of arformoterol administered for 12 weeks as maintenance treatment in patients…NCT00064402·Jasper, Alabama and 64 others

CompletedAdherence Study in COPD PatientsA randomized clinical study to assess the impact of Symbicort® pMDI medication reminders on adherence in COPD patientsNCT02864342·Clearwater, Florida and 7 others

PreviousPage 8 of 10Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia